Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

N-(2-aminoethyl)-4-(5-(4-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide MeSH Supplementary Concept Data 2025


MeSH Supplementary
N-(2-aminoethyl)-4-(5-(4-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
Unique ID
C504153
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C504153
Entry Term(s)
TT 101
TT-101
TT101 cpd
Registry Numbers
0
Heading Mapped to
*Pyrazoles
*Benzenesulfonamides
Frequency
2
Note
a celecoxib derivative that induces apoptosis in synovial fibroblasts; inhibits cyclooxygenase-2; structure in first source
Source
J Pharmacol Exp Ther 2005 Aug;314(2):796-803
Date of Entry
2005/09/28
Revision Date
2023/06/22
N-(2-aminoethyl)-4-(5-(4-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide Preferred
TT 101 Narrower
page delivered in 0.003s